4.6 Review

Roles of TRAF6 in Central Nervous System

Journal

CURRENT NEUROPHARMACOLOGY
Volume 16, Issue 9, Pages 1306-1313

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X16666180412094655

Keywords

TRAF6; E3 ubiquitin ligase; ubiquitination; inflammation; ROS; central nervous system diseases

Funding

  1. Project of Jiangsu Provincial Medical Innovation Team [CXTDA2017003]
  2. Jiangsu Provincial Medical Youth Talent [QNRC2016728]
  3. Suzhou Key Medical Center [Szzx201501]
  4. National Natural Science Foundation of China [81571121]
  5. Natural Science Foundation of Jiangsu Province [BK20170363]
  6. Scientific Department of Jiangsu Province [BL2014045]
  7. Suzhou Government [SYS201608, LCZX201601]
  8. Jiangsu Province [16KJB320008]

Ask authors/readers for more resources

Tumor necrosis factor receptor-associated factor (TRAF) is an important binding protein of tumor necrosis factor (TNF) superfamily and the toll/IL-1 receptor (TIR) superfamily, which play an important role in innate immunity and acquired immunity. TRAFs family have 7 members (TRAF1-7), and TRAF6 has its special facture and biological function. TRAF6 has two special domains: C-terminal domain and N-terminal domain, which could integrate with multiple kinases and regulate signaling pathway function as an E3 ubiquitin ligase. Studies have increasingly found that TRAF6 is closely related to central nervous system diseases, such as stroke, Traumatic brain injury, neurodegenerative diseases and neuropathic pain. Further research on the pathophysiological mechanism may be expected to become the new targets for the treatment of central nervous system diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available